Propofol Administered by Gastroenterologists by Target Controlled Infusion Pump During Endoscopy

• Status: Completed
• Trial end date: 2014-05-01
• Target enrollment: 0
• Participant gender: All

Summary

Many studies address safety of non-anesthesiologist propofol sedation (NAPS) for gastrointestinal endoscopy. Target Controlled Infusion (TCI) is a sophisticated tool for providing optimal sedation regimen and avoiding under or oversedation. The objective of the study is to compare standard moderate sedation during upper endoscopy and colonoscopy versus propofol NAPS.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Università Vita-Salute San Raffaele
• Treatments: Midazolam; Propofol

Criteria

Inclusion Criteria:

• age < 18 years

• American Society of Anesthesiologists risk I-II

• patients undergoing to Gastroscopy or Colonoscopy

Exclusion Criteria:

• significant systemic disease

• allergic reactions to any of study drugs

• chronic use of opioids or psychiatric disorders

• pregnancy

• Mallampati score > 2

• age < 18 years